📍#CLINICAL24 Feature

Diagnostic excellence, clinical expertise and the power of partnerships

Diagnostic excellence lies at the heart of modern healthcare, ensuring patients receive timely, accurate, and actionable information to support the best possible outcomes. Achieving this standard requires a continuous commitment to innovation, quality, and evidence-based practice across the diagnostic pathway. While no single discipline can address the complex healthcare challenges facing patients today, collaboration between clinicians, laboratory professionals, researchers, healthcare organizations, policymakers, and industry partners plays a vital role in advancing the field. Together, these contributions help accelerate the translation of scientific discovery into clinical practice, support the adoption of innovative technologies, and strengthen the delivery of high-quality diagnostic services.

As part of #CLINICAL24, SelectScience brings together leading experts from across the healthcare and diagnostics landscape to showcase real-world examples of diagnostic excellence and explore the factors driving progress in laboratory medicine. Through discussions, interviews, and case studies, our contributors examine how innovation, expertise, and collaboration are improving the accuracy and impact of diagnostic testing, strengthening clinical decision-making, enhancing laboratory performance, and helping healthcare systems meet the evolving needs of patients.

CLINICAL24 Forum: Advancing sepsis care through collaboration and innovation

Sponsored by Danaher

This expert forum brings together leaders in infectious diseases, clinical microbiology, laboratory medicine, and antimicrobial stewardship to explore the growing role of host-response testing in the assessment of acute infection. Drawing on both clinical and laboratory perspectives, the discussion will examine how these innovative approaches can help distinguish bacterial from viral illness, support more informed treatment decisions, and enhance diagnostic confidence when rapid answers are needed.

The panel will also discuss the practical considerations for implementing host-response testing and its potential to support improved sepsis recognition and patient management across healthcare settings.

Danaher’s vision for diagnostic excellence in infectious disease

In this interview, Kelly Sager, Vice President and Franchise Head of Infectious Disease and Acute Care for Danaher’s diagnostics businesses, discusses the company’s vision for improving infectious disease testing through diagnostic excellence, innovation, and collaboration. The conversation explores the growing role of diagnostic stewardship, focusing on how healthcare providers can achieve better patient outcomes by ensuring the right tests are used at the right time to support faster, more confident clinical decisions

Watch video

Webinar: Driving excellence in monoclonal protein testing

Join Dr. Stephanie Brunelle for an accredited webinar exploring current and emerging approaches to monoclonal protein testing in plasma cell disorders. This session will examine the strengths and limitations of conventional methods, including SPEP, IFE, and serum free light chain testing, while addressing common analytical challenges such as therapeutic antibody interference and antigen excess. Attendees will also discover how mass spectrometry is advancing monoclonal protein detection and characterization.

Test vs. diagnostic: why sepsis tests don't need to be perfect to have an impact

Explore why sepsis testing does not need to be perfect to make a meaningful difference in patient care. This interview with Dr. Ephraim Tsalik, Danaher, examines the balance between test performance and clinical utility, highlighting how earlier insights can support faster treatment decisions, improve outcomes, and help address one of healthcare's most urgent challenges.

Read article

The diagnostics and clinical leadership community

Collaboration is at the heart of modern laboratory medicine, bringing together diverse expertise to improve diagnostic accuracy, accelerate innovation, and enhance patient outcomes. From cross-sector partnerships and multidisciplinary teams to industry-led initiatives and clinical collaboration, the diagnostics community continues to demonstrate the power of working together to solve healthcare challenges.

Stay connected with the latest expert insights, scientific developments, and educational content from across the diagnostics and clinical leadership community.

Want the latest news, interviews, webinars, and resources delivered straight to your inbox? Become a member for free here.

Hospital case study highlights assay choice importance for myeloma patients

This case study summarizes clinical findings from a comparative evaluation of serum free light chain assays in patients with plasma cell disorders. Discover how discrepancies between assay results influenced diagnosis, disease monitoring, and treatment decisions, including cases involving delayed therapy, misclassification of disease progression, and serious patient outcomes. Plus, learn about the clinical implications of free light chain assay selection and the importance of accurate monitoring in patient management.

Download case study

AI, automation, and partnerships rewrite the diagnostics playbook

From precision medicine and companion diagnostics to the growing importance of strategic partnerships across the healthcare ecosystem, Puneet Sarin, Senior Vice President and President of Specialty Diagnostics at Thermo Fisher Scientific, discusses the trends already shaping the future of diagnostics. Hear how advances in automation, artificial intelligence, and less invasive monitoring approaches are helping to create smarter clinical laboratories, deliver deeper clinical insights, and improve patient outcomes.

Watch video